BIOL

Biolase, Inc.
BIOL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

17 hedge funds and large institutions have $3.59M invested in Biolase, Inc. in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$129K
2
+$98.2K
3
+$33.5K
4
UBS Group
UBS Group
Switzerland
+$12.8K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.75K

Top Sellers

1
-$39K
2
-$20.4K
3
-$728
4
APA
American Portfolios Advisors
New York
-$73
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.7M
2
$668K
3
$321K
4
$302K
5
$256K
6
$133K
7
$46K
8
$43K
9
$42K
10
$27K
11
$21K
12
$14K
13
$5K
14
$5K
15
$4K
16
$39